Company No:
Contents
| Note | 31.12.2025 | 31.12.2024 | ||
| € | € | |||
| Fixed assets | ||||
| Investments | 3 |
|
|
|
| 11,058,372 | 3,616,048 | |||
| Current assets | ||||
| Debtors | 4 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 11,020,478 | 11,211,372 | |||
| Creditors: amounts falling due within one year | 5 | (
|
(
|
|
| Net current assets | 11,001,234 | 11,069,644 | ||
| Total assets less current liabilities | 22,059,606 | 14,685,692 | ||
| Net assets |
|
|
||
| Capital and reserves | ||||
| Called-up share capital | 6 |
|
|
|
| Share premium account |
|
|
||
| Other reserves |
|
|
||
| Profit and loss account |
|
(
|
||
| Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of TDI Renewables Ltd (registered number:
|
A Vardimon
Director |
I Isman
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.
TDI Renewables Limited (the Company) is a private company, limited by shares, incorporated on 26 June 2024 in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 1 Fore Street Avenue, London, EC2Y 9DT.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in EUR which is the functional currency of the Company and rounded to the nearest €.
The current year figures are presented for the period from 1 January 2025 until 31 December 2025, and are therefore not entirely comparable with the prior six month period.
Exchange differences are recognised in the Statement of Comprehensive Income in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Defined contribution schemes
The company operates a defined contribution scheme. The amount charged to the Statement of Comprehensive Income in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Comprehensive Income as described below.
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.
Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Comprehensive Income.
Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.
Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Equity instruments
Equity instruments issued by the company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.
| Year ended 31.12.2025 |
Period from 26.06.2024 to 31.12.2024 |
||
| Number | Number | ||
| Number of persons employed by the company during the period, including directors |
|
|
| 31.12.2025 | 31.12.2024 | ||
| € | € | ||
| Subsidiary undertakings |
|
|
|
| Participating interests |
|
|
|
| 11,058,372 | 3,616,048 |
Investments in subsidiaries
| 31.12.2025 | |
| € | |
| Cost | |
| At 01 January 2025 |
|
| Additions |
|
| Disposals | (
|
| Movement in fair value | 7,491,556 |
| At 31 December 2025 |
|
| Carrying value at 31 December 2025 |
|
| Carrying value at 31 December 2024 |
|
| Investments in associates | Total | ||
| € | € | ||
| Cost or valuation before impairment | |||
| At 01 January 2025 |
|
|
|
| At 31 December 2025 |
|
|
|
| Carrying value at 31 December 2025 |
|
|
|
| Carrying value at 31 December 2024 |
|
|
The fair value of investments has been determined with reference to a valuation provided by the management.
| 31.12.2025 | 31.12.2024 | ||
| € | € | ||
| Amounts owed by group undertakings |
|
|
|
| Other debtors |
|
|
|
|
|
|
| 31.12.2025 | 31.12.2024 | ||
| € | € | ||
| Trade creditors |
|
|
|
| Amounts owed to group undertakings |
|
|
|
| Other taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|
| 31.12.2025 | 31.12.2024 | ||
| € | € | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 15,000,000 | 4,780,000 | ||
| 15,001,248 | 4,781,034 |
On 1 August 2025, 65 preferred A shares were issued at a nominal value of €10,000 for a cash consideration of €650,000.
On 30 October 2025, 82 preferred A shares were issued at a nominal value of €10,000 for a cash consideration of €820,000.
On 3 February 2025, 578 preferred B shares were issued at a nominal value of €10,000 for a cash consideration of €5,780,000.
On 1 August 2025, 134 preferred B shares were issued at a nominal value of €10,000 for a cash consideration of €1,340,000.
On 30 October 2025, 163 preferred B shares were issued at a nominal value of €10,000 for a cash consideration of €1,630,000.
Where possible, the company has taken advantage of the exemption conferred by FRS 102 section 33.1A from the requirement to disclose transactions with other wholly owned group undertakings.
On 29 March 2026, the company issued 300 preferred B shares of €10,000 each for a total cash consideration of €3,000,000.
On 29 March 2026, 54,892 ordinary shares were issued at a nominal value of €0.001.
On 29 March 2026, the Company entered into an Amended and Restated Shareholders’ Agreement between the Company, TDI Wind and Solar Energy Ltd.(“TDI”), Helios 5 RE Development, Limited Partnership (the “Investor”), and certain other shareholders, amending the original agreement dated 25 November 2024.
Under the terms of the agreement, the shareholders have committed to provide additional funding to the Company in tranches up to 31 December 2026, including up to €3 million from the Investor and €1.5 million from TDI under the first tranche, up to €2.75 million from the Investor under the second tranche, and an optional additional €1 million investment subject to a qualified financing round. As of the date of approval of these financial statements, the shareholders have provided the Company with a total aggregate amount of €4.5 million out of the aforementioned funding.
The agreement also includes exit provisions under which the Investor holds contractual rights in relation to an exit event, including drag-along rights and protections designed to secure a minimum target return on its investment.